Advertisement
Original article| Volume 55, ISSUE 2, P118-125, January 15, 2004

A rare polymorphism affects a Mitogen-Activated Protein kinase site in synapsin III: possible relationship to schizophrenia

  • Barbara Porton
    Affiliations
    Nathan Kline Institute for Psychiatric Research (BP, LED, H-TK), Orangeburg, New York, USA and the Department of Psychiatry (BP, LED, H-TK), New York University, New York, New York, USA

    Laboratory of Molecular and Cellular Neuroscience (BP, H-TK), Rockefeller University, New York, New York, USA
    Search for articles by this author
  • Adriana Ferreira
    Affiliations
    Department of Cell and Molecular Biology and Institute for Neuroscience (AF), Northwestern University, Chicago, Illinois, USA
    Search for articles by this author
  • Lynn E DeLisi
    Affiliations
    Nathan Kline Institute for Psychiatric Research (BP, LED, H-TK), Orangeburg, New York, USA and the Department of Psychiatry (BP, LED, H-TK), New York University, New York, New York, USA
    Search for articles by this author
  • Hung-Teh Kao
    Correspondence
    Address reprint requests to Hung-Teh Kao, M.D., Ph.D., Nathan Kline Institute, 140 Old Orangeburg Road, Orangeburg NY 10962, USA.
    Affiliations
    Nathan Kline Institute for Psychiatric Research (BP, LED, H-TK), Orangeburg, New York, USA and the Department of Psychiatry (BP, LED, H-TK), New York University, New York, New York, USA

    Laboratory of Molecular and Cellular Neuroscience (BP, H-TK), Rockefeller University, New York, New York, USA
    Search for articles by this author

      Abstract

      Background

      Synapsin III plays a role in neuronal plasticity and maps to chromosome 22q12-13, a region suggested to be linked to schizophrenia. To determine if synapsin III plays a role in this disease, we searched for polymorphisms in this gene in patients with schizophrenia and controls.

      Methods

      The synapsin III gene was initially sequenced from 10 individuals with schizophrenia to identify polymorphisms. Association analysis was then performed using 118 individuals with schizophrenia and 330 population controls. Synapsin III expression was studied by immunoblot analyses, and phosphorylation sites were mapped by sequencing trypsin-digested synapsin III fragments phosphorylated with phosphorus-32.

      Results

      A rare, missense polymorphism, S470N, was identified in the synapsin III gene and appeared more frequently in individuals with schizophrenia than in controls (p = .0048). The site affected by the polymorphism, Ser470, was determined to be a substrate for mitogen-activated protein kinase, a downstream effector of neurotrophin action. Phosphorylation at Ser470 was increased during neonatal development and in response to neurotrophin-3 in cultured hippocampal neurons.

      Conclusions

      Our observations suggest an association of a rare polymorphism in synapsin III with schizophrenia, but further studies will be required to clarify its role in this disease.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Badner J.A.
        • Gershon E.S.
        Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia.
        Mol Psychiatry. 2002; 7: 405-411
        • Bähler M.
        • Greengard P.
        Synapsin I bundles F-actin in a phosphorylation-dependent manner.
        Nature. 1987; 326: 704-707
        • Benes F.M.
        Evidence for neurodevelopment disturbances in anterior cingulate cortex of post-mortem schizophrenic brain.
        Schizophr Res. 1991; 5: 187-188
        • Berrettini W.H.
        Susceptibility loci for bipolar disorder.
        Biol Psychol. 2000; 47: 245-251
        • Browning M.D.
        • Dudek E.M.
        • Rapier J.L.
        • Leonard S.
        • Freedman R.
        Significant reductions in synapsin but not synaptophysin specific activity in the brains of some schizophrenics.
        Biol Psychol. 1993; 34: 529-535
        • Cardno A.G.
        • Rijsdijk F.V.
        • Sham P.C.
        • Murray R.M.
        • McGuffin P.
        A twin study of genetic relationships between psychotic symptoms.
        Am J Psychiatry. 2002; 159: 539-545
        • Chin L.S.
        • Li L.
        • Ferreira A.
        • Kosik K.S.
        • Greengard P.
        Impairment of axonal development and of synaptogenesis in hippocampal neurons of synapsin I-deficient mice.
        Proc Natl Acad Sci U S A. 1995; 92: 9230-9234
        • Chong V.Z.
        • Young L.T.
        • Mishra R.K.
        CDNA microarray technology reveals differential gene expression in the brain following haloperidol treatment.
        J Neurochem. 2002; 82: 1533-1539
        • Coon H.
        • Holik J.
        • Hoff M.
        • Reimherr F.
        • Wender P.
        • Myles-Worsley M.
        • et al.
        Analysis of chromosome 22 markers in nine schizophrenia pedigrees.
        Am J Med Genet. 1994; 54: 72-79
        • Czernik A.J.
        • Pang D.T.
        • Greengard P.
        Amino acid sequences surrounding the cAMP-dependent and calcium/calmodulin-dependent phosphorylation sites in rat and bovine synapsin I.
        Proc Natl Acad Sci U S A. 1987; 84: 7518-7522
        • DeLisi L.E.
        • Craddock N.J.
        • Detera-Wadleigh S.
        • Foroud T.
        • Gejman P.
        • Kennedy J.L.
        • et al.
        Update on chromosomal locations for psychiatric disorders.
        Am J Med Genet. 2000; 96: 434-449
        • DeLisi L.E.
        • Shaw S.
        • Crow T.J.
        • Shields G.
        • Smith A.B.
        • Larach V.W.
        • et al.
        Lack of evidence for linkage to chromosomes 13 and 8 for schizophrenia and schizoaffective disorder.
        Am J Med Genet. 2000; 96: 235-239
        • DeLisi L.E.
        • Shaw S.H.
        • Crow T.J.
        • Shields G.
        • Smith A.B.
        • Larach N.W.
        • et al.
        A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder.
        Am J Psychiatry. 2002; 159: 803-812
        • Feng J.
        • Chi P.
        • Blanpied T.A.
        • Xu Y.
        • Magarinos A.M.
        • Ferreira A.
        • et al.
        Regulation of neurotransmitter release by synapsin III.
        J Neurosci. 2002; 22: 4372-4380
        • Ferreira A.
        • Kao H.T.
        • Feng J.
        • Rapoport M.
        • Greengard P.
        Synapsin III.
        J Neurosci. 2000; 20: 3736-3744
        • Garner C.
        • Kelly M.
        • Cardon L.
        • Joslyn G.
        • Carey A.
        • LeDuc C.
        • et al.
        Linkage analyses of schizophrenia to chromosome 6p24-p22.
        Am J Med Genet. 1996; 67: 595-610
        • Gill M.
        • Vallada H.
        • Collier D.
        • Sham P.
        • Holmans P.
        • Murray R.
        • et al.
        A combined analysis of D22S278 marker alleles in affected sib-pairs.
        Am J Med Genet. 1996; 67: 40-45
        • Gill M.
        • Vallada H.
        • Collier D.
        • Sham P.
        • Holmans P.
        • Murray R.
        • et al.
        A transmission disequilibrium and linkage analysis of D22S278 marker alleles in 574 families.
        Schizophr Res. 1998; 32: 115-121
        • Goslin K.
        • Asmussen H.
        • Banker G.
        Rat hippocampal neurons in low-density culture.
        in: Banker G.A. Goslin K. Culturing Nerve Cells. 2nd ed. The MIT Press, Cambridge, MA1998: 339-370
        • Gottesman I.I.
        • Shields J.
        Schizophrenia.
        Cambridge University Press, New York1998
        • Grebb J.A.
        • Greengard P.
        An analysis of synapsin II, a neuronal phosphoprotein, in postmortem brain tissue from alcoholic and neuropsychiatrically ill adults and medically ill children and young adults.
        Arch Gen Psychiatry. 1990; 47: 1149-1156
        • Greengard P.
        • Valtorta F.
        • Czernik A.J.
        • Benfenati F.
        Synaptic vesicle phosphoproteins and regulation of synaptic function.
        Science. 1993; 259: 780-785
        • Huang E.J.
        • Reichardt L.F.
        Neurotrophins.
        Ann Rev Neurosci. 2001; 24: 677-736
        • Imai K.
        • Harada S.
        • Kawanishi Y.
        • Tachikawa H.
        • Okubo T.
        • Suzuki T.
        Polymorphisms in the promoter and coding regions of the synapsin III gene. A lack of association with schizophrenia.
        Neuropsychobiology. 2001; 43: 237-241
        • Jovanovic J.N.
        • Benfenati F.
        • Siow Y.L.
        • Sihra T.S.
        • Sanghera J.S.
        • Pelech S.L.
        • et al.
        Neurotrophins stimulate phosphorylation of synapsin I by MAP kinase and regulate synapsin I-actin interactions.
        Proc Natl Acad Sci U S A. 1996; 93: 3679-3683
        • Jovanovic J.N.
        • Czernik A.J.
        • Fienberg A.A.
        • Greengard P.
        • Sihra T.S.
        Synapsins as mediators of BDNF-enhanced neurotransmitter release.
        Nat Neurosci. 2000; 3: 323-329
        • Kao H.-T.
        • Porton B.
        • Czernik A.J.
        • Feng J.
        • Yiu G.
        • Häring M.
        • et al.
        A third member of the synapsin gene family.
        Proc Natl Acad Sci U S A. 1998; 95: 4667-4672
        • Kao H.-T.
        • Porton P.
        • Hilfiker S.
        • Stefani G.
        • Pieribone V.A.
        • DeSalle R.
        • et al.
        Molecular evolution of the synapsin gene family.
        J Exp Zoolog Part B Mol Dev Evol. 1999; 285: 360-377
        • Kao H.-T.
        • Song H.J.
        • Porton B.
        • Ming G.-L.
        • Abraham M.
        • Hoh J.
        • et al.
        A PKA-dependent molecular switch in synapsins regulates neurite outgrowth.
        Nat Neurosci. 2002; 5: 431-437
        • Kyosseva S.V.
        • Elbein A.D.
        • Hutton T.L.
        • Griffin W.S.T.
        • Mrak R.E.
        • Sturner W.Q.
        • et al.
        Increased levels of transcription factors Elk-1, cyclic adenosine monophosphate response element-binding protein, and activating transcription factor 2 in the cerebellar vermis of schizophrenic patients.
        Arch Gen Psychiatry. 2000; 57: 685-691
        • Laemmli U.K.
        Cleavage of structural protein during the assembly of the head of the bacteriophage T4.
        Nature. 1970; 277: 680-685
        • Laval S.H.
        • Dann J.C.
        • Butler R.J.
        • Loftus J.
        • Rue J.
        • Leask S.J.
        • et al.
        Evidence for linkage to psychosis and cerebral asymmetry (relative hand skill) on the X chromosome.
        Am J Med Genet. 1998; 81: 420-427
        • Lewis C.M.
        • Levinson D.F.
        • Wise L.H.
        • DeLisi L.E.
        • Straub R.E.
        • Hovatta I.
        • et al.
        Genome scan meta-analysis of schizophrenia and bipolar disorder, part II.
        Am J Hum Genet. 2003; 73: 34-48
        • Matsubara M.
        • Kusubata M.
        • Ishiguro K.
        • Uchida T.
        • Titani K.
        • Taniguchi H.
        Site-specific phosphorylation of synapsin I by mitogen-activated protein kinase and Cdk5 and its effects on physiological functions.
        J Biol Chem. 1996; 271: 21108-21113
        • McGlashan T.H.
        • Hoffman R.E.
        Schizophrenia as a disorder of developmentally reduced synaptic connectivity.
        Arch Gen Psychiatry. 2000; 57: 637-648
        • Mirnics K.
        • Middleton F.A.
        • Marquez A.
        • Lewis D.A.
        • Levitt P.
        Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex.
        Neuron. 2000; 28: 53-67
        • Moises H.W.
        • Yang L.
        • Li T.
        • Havsteen B.
        • Fimmers R.
        • Baur M.P.
        • et al.
        Potential linkage disequilibrium between schizophrenia and locus D22S278 on the long arm of chromosome 22.
        Am J Med Genet. 1995; 60: 465-467
        • Nicolson R.
        • Lenane M.
        • Hamburger S.D.
        • Fernandez T.
        • Bedwell J.
        • Rapoport J.L.
        Lessons from childhood-onset schizophrenia.
        Brain Res Brain Res Rev. 2000; 31: 147-156
        • Nowakowski C.
        • Kaufmann W.A.
        • Adlassnig C.
        • Maier H.
        • Salimi K.
        • Jellinger K.A.
        • et al.
        Reduction of chromogranin B-like immunoreactivity in distinct subregions of the hippocampus from individuals with schizophrenia.
        Schizophr Res. 2002; 58: 43-53
        • Nurnberger J.I.
        • Blehar M.C.
        • Kaufman C.A.
        • York-Cooler C.
        • Simpson S.G.
        • Harkavy-Friedman J.
        • et al.
        Diagnostic interview for genetic studies.
        Arch Gen Psychiatry. 1994; 51: 849-862
        • Ohmori O.
        • Shinkai T.
        • Hori H.
        • Kojima H.
        • Nakamura J.
        Synapsin III gene polymorphisms and schizophrenia.
        Neurosci Lett. 2000; 279: 125-127
        • Ohtsuki T.
        • Ichiki R.
        • Toru M.
        • Arinami T.
        Mutational analysis of the synapsin III gene on chromosome 22q12-q13 in schizophrenia.
        Psychiatry Res. 2000; 94: 1-7
        • Pang L.
        • Sawada T.
        • Decker S.J.
        • Saltiel A.R.
        Inhibition of MAP kinase blocks the differentiation of PC-12 cells induced by nerve growth factor.
        J Biol Chem. 1995; 270: 13585-13588
      1. Pfohl B, Blum N, Zimmerman M, Stangl D (1990): Structured Interview for DSM-III-R Personality Disorders-Revised (SIDP-R). Iowa City, IA: Department of Psychiatry, University of Iowa

        • Pieribone V.A.
        • Porton B.
        • Rendon R.
        • Greengard P.
        • Kao H.-T.
        Expression of synapsin III in nerve terminals and neurogenic regions of the adult brain.
        J Comp Neurol. 2002; 454: 105-114
        • Polymeropoulos M.H.
        • Coon H.
        • Byerley W.
        • Gershon E.S.
        • Goldin L.
        • Crow T.J.
        • et al.
        Search for a schizophrenia susceptibility locus on human chromosome 22.
        Am J Med Genet. 1994; 54: 93-99
        • Porton B.
        • Kao H.-T.
        • Greengard P.
        Characterization of transcripts from the synapsin III gene locus.
        J Neurochem. 1999; 73: 2266-2271
        • Potash J.B.
        • Zandi P.P.
        • Willour V.L.
        • Lan T.H.
        • Huo Y.
        • Avramopoulos D.
        • et al.
        Suggestive linkage to chromosomal regions 13q31 and 22q12 in families with psychotic bipolar disorder.
        Am J Psychiatry. 2003; 160: 680-686
        • Pulver A.E.
        • Karayiorgou M.
        • Wolyniec P.S.
        • Lasseter V.K.
        • Kasch L.
        • Nestadt G.
        • et al.
        Sequential strategy to identify a susceptibility gene for schizophrenia.
        Am J Med Genet. 1994; 54: 36-43
        • Riabowol K.
        • Draetta G.
        • Brizuela L.
        • Vandre D.
        • Beach D.
        The cdc2 kinase is a nuclear protein that is essential for mitosis in mammalian cells.
        Cell. 1989; 57: 393-401
        • Sambrook J.
        • Fritsch E.F.
        • Maniatis T.
        Molecular Cloning: A Laboratory Manual.
        2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY1989
        • Schwab S.G.
        • Lerer B.
        • Albus M.
        • Maier W.
        • Hallmayer J.
        • Fimmers R.
        • et al.
        Potential linkage for schizophrenia on chromosome 22q12-q13.
        Am J Med Genet. 1995; 60: 436-443
        • Shaw S.H.
        • Kelly M.
        • Smith A.B.
        • Shields G.
        • Hopkins P.J.
        • Loftus J.
        • et al.
        A genome-wide search for schizophrenia susceptibility genes.
        Am J Med Genet. 1998; 81: 364-376
        • Sklar P.
        Linkage analysis in psychiatric disorders.
        Ann Rev Genomics Hum Genet. 2002; 3: 371-413
        • Spitzer R.L.
        • Endicott J.
        Schedule for Affective Disorders and Schizophrenia (SADS).
        Biometrics Research Division, New York State Psychiatric Institute, New York1978
        • Takahashi S.
        • Cui Y.H.
        • Kojima T.
        • Han Y.H.
        • Zhou R.L.
        • Kamioka M.
        • et al.
        Family-based association study of markers on chromosome 22 in schizophrenia using African-American, European-American, and Chinese families.
        Am J Med Genet. 2003; 120B: 11-17
        • Tsai M.T.
        • Hung C.C.
        • Tsai C.Y.
        • Liu M.Y.
        • Su Y.C.
        • Chen Y.H.
        • et al.
        Mutation analysis of synapsin III gene in schizophrenia.
        Am J Med Genet. 2002; 114: 79-83
        • Vallada H.P.
        • Curtis D.
        • Sham P.C.
        • Murray R.M.
        • McGuffin P.
        • Nanko S.
        • et al.
        Chromosome 22 markers demonstrate transmission disequilibrium with schizophrenia.
        Psychiatr Genet. 1995; 5: 127-130
        • Vallada H.P.
        • Gill M.
        • Sham P.
        • Lim L.C.
        • Nanko S.
        • Asherson P.
        • et al.
        Linkage studies on chromosome 22 in familial schizophrenia.
        Am J Med Genet. 1995; 60: 139-146
        • Vawter M.P.
        • Thatcher L.
        • Usen N.
        • Hyde T.M.
        • Kleinman J.E.
        • Freed W.J.
        Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia.
        Mol Psychiatry. 2002; 7: 571-578
        • Weinberger D.R.
        Implications of normal brain development for the pathogenesis of schizophrenia.
        Arch Gen Psychiatry. 1987; 44: 660-667
        • Wildenauer D.B.
        • Schwab S.G.
        • Maier W.
        • Detera-Wadleigh S.D.
        Do schizophrenia and affective disorder share susceptibility genes?.
        Schizophr Res. 1999; 39: 107-111
        • Wolf S.S.
        • Hyde T.M.
        • Weinberger D.R.
        Neurobiology of schizophrenia.
        Curr Opin Neurol Neurosurg. 1993; 6: 86-92